LYNGE, DENMARK — WSA reported 3% organic revenue growth in the third quarter of its 2025/26 financial year (April 1–June 30, 2026), with revenue reaching €624 million. EBITDA before special items increased 12% to €119 million, while the corresponding margin rose 2 percentage points to 19.1%.
The hearing healthcare group also confirmed and narrowed its outlook for the full financial year, now expecting organic revenue growth of 1–2%, compared with its previous guidance of 0–4%.
“Organic revenue growth in the third quarter was in line with expectations, with momentum strengthening towards the end of the quarter. At the same time, profitability improved significantly, reflecting continued execution of our strategic priorities. With the first nine months of the financial year complete, WSA confirms and narrows its guidance for FY 2025/26 to 1-2% organic growth. We are also excited to launch Signia MaX, the world’s first hearing aid platform with four deep neural networks that simultaneously understand speech, noise, the environment, and the wearer’s own voice. By moving beyond the limitations of one-dimensional AI, Signia MaX fundamentally redefines the possibilities of hearing care. It enables hearing care professionals to deliver even better outcomes, setting new standards for what wearers can expect from their hearing aids.”
–Jan Mäkelä, CEO of WSA
Q3 FY 2025/26 Highlights
- WSA Group reported organic revenue growth of 3%, compared with a 4% decline in the same quarter last year, bringing revenue to €624 million. Reported revenue increased 1%.
- The wholesale business recorded a 2% organic revenue decline, which WSA attributed to the timing of product launches.
- Consumer-facing businesses delivered 8% organic growth, driven by the company’s Online, Retail and Managed Care businesses.
- Organic revenue growth varied by region, with the Americas up 4%, EMEA flat at 0%, and APAC up 3%.
- EBITDA before special items increased 12% to €119 million, compared with €106 million in the prior-year quarter.
- The EBITDA margin before special items increased from 17.1% to 19.1%. WSA attributed the improvement to relatively stronger growth in consumer-facing businesses, operational efficiencies, cost controls and structural cost reductions implemented during FY 2024/25.
- During the quarter, WSA launched Signia MaX, Powered by Acoustic Intelligence™. The new hearing aid platform uses four task-specific deep neural networks (DNNs) designed to simultaneously analyze speech, noise, the listening environment and the wearer’s own voice, allowing processing decisions to account for multiple aspects of the acoustic environment in real time.
Q3 Financial Results
| Metric | Q3 FY 2025/26 | Q3 FY 2024/25 |
|---|---|---|
| Revenue | €624 million | €621 million |
| Gross profit | €397 million | €388 million |
| EBITDA before special items | €119 million | €106 million |
| Reported EBITDA | €119 million | €105 million |
| EBIT | €82 million | €72 million |
| Profit for the period | €24 million | €20 million |
| Organic growth | 3% | -4% |
| Gross profit margin | 63.6% | 62.5% |
| EBITDA margin before special items | 19.1% | 17.1% |
| Reported EBITDA margin | 19.1% | 16.9% |
| EBIT margin | 13.1% | 11.6% |
First Nine Months of FY 2025/26
For the first nine months of the financial year, WSA reported 1% organic revenue growth, compared with no organic growth during the same period last year. Revenue totaled €1.881 billion, although reported revenue declined 4% due to currency headwinds.
EBITDA before special items totaled €347 million, with the margin improving by 1.2 percentage points.
With nine months of FY 2025/26 completed, WSA narrowed its full-year organic revenue growth outlook to 1–2%, from its previous range of 0–4%. The company continues to expect its EBITDA margin before special items to improve by approximately 1 percentage point compared with FY 2024/25.
The full Q3 FY 2025/26 Financial Report is available at WSA.com/investors/reports.
About WSA
WSA is a leading global pure-play hearing healthcare group, pioneering innovative technologies for over 140 years, helping millions of people with hearing loss regain the joy of hearing, engage in meaningful conversations, and participate fully in society. WSA operates in over 130 markets and employs around 12,000 people across our hearing aid portfolio, which includes Widex and Signia, and a global network of hearing care professionals and consumer-facing businesses. WSA is privately owned by the Tøpholm and Westermann families, the Lundbeck Foundation, EQT and ATHOS KG. As a global leader, our ambition is to unlock human potential by making wonderful sound part of everyone’s life.
Source: WSA
